
Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series
Author(s) -
Behrooz Ataei,
Mahsa Khodadoostan,
Babk Pouria,
Peyman Adibi
Publication year - 2016
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/2279-042x.185714
Subject(s) - medicine , gastroenterology , hepatitis b virus , serology , alanine transaminase , hepatitis b , viral load , hepatitis , population , antibody , virus , immunology , virology , environmental health
Tenofovir is among the first-line treatments for chronic hepatitis B (CHB) virus infection. We evaluated the efficacy and safety of Tenofovir in treatment of Iranian patients with CHB.